 |
|
Informing Patients About Tardive Dyskinesia
Mark R. Munetz, MD;
Loren H. Roth, MD, MPH
Arch Gen Psychiatry. 1985;42(9):866-871.
Abstract
• The effects of a formal (written) approach v an informal (oral) approach to obtaining informed consent for neuroleptic treatment were compared in 25 schizophrenic outpatients with tardive dyskinesia. Both groups had significant Increases in knowledge, but only the informal/oral presentation group retained significant new knowledge at two-month follow-up. Overall, patients did not learn the information deemed most relevant for rational decision making about neuroleptic treatment. Younger patients started out with more knowledge and retained significant new knowledge at follow-up. All study patients remained in treatment and all but one remained on neuroleptic regimens. There was no increase in relapse or treatment noncompliance in the study population compared with a comparison group. While information about tardive dyskinesia can be safely disclosed to schizophrenic outpatients, such disclosure is evidently most meaningful when repeated informally in the context of a therapeutic relationship.
Author Affiliations
From the Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine.
Footnotes
Accepted for publication Sept 27, 1984.
Reprint requests to Western Psychiatric Institute and Clinic, 3811 O'Hara St, Pittsburgh, PA 15213 (Dr Munetz).
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Survey of Depot Antipsychotic Prescribing in Southern Adelaide
Herriot and Kheirani
Australas Psychiatry 2005;13:253-257.
ABSTRACT
| FULL TEXT
|
